Recombinant Nectria haematococca Enolase-phosphatase E1 (UTR4)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchase method and location. Consult your local distributor for specifics. All proteins ship with blue ice packs. Dry ice shipping is available upon request for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
UTR4; NECHADRAFT_70452Enolase-phosphatase E1; EC 3.1.3.77; 2,3-diketo-5-methylthio-1-phosphopentane phosphatase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-238
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Nectria haematococca (strain 77-13-4 / ATCC MYA-4622 / FGSC 9596 / MPVI) (Fusarium solani subsp. pisi)
Target Names
UTR4
Target Protein Sequence
MTLNLAEYDV LVFDIEGTVC PISFVKDVLF PYALEALPKV LDQEWDSPEF AKYRDAFPEE YRNSRPDFEA HVRDLVKRDV KIAYLKSLQG YLWLQGYKSG DIVAPLFPDV DPFFNQAVKD GKKIIIYSSG SVPAQKLLFS HTNSEKSDMT PLIADYFDTT NAGPKTEVDS YRKIISSHPE HKDLGRWLFL SDNIHEVSAA VEAGIRSVPV IRDGNAPLPP DNSLTKLAIS EFKHSEDA
Uniprot No.

Target Background

Function
This bifunctional enzyme catalyzes the enolization of 2,3-diketo-5-methylthiopentyl-1-phosphate (DK-MTP-1-P) to 2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate (HK-MTPenyl-1-P), which is then dephosphorylated to 1,2-dihydroxy-3-keto-5-methylthiopentene (DHK-MTPene).
Database Links
Protein Families
HAD-like hydrolase superfamily, MasA/MtnC family
Subcellular Location
Cytoplasm. Nucleus.

Q&A

Basic Research Questions

Advanced Research Questions

  • What are the optimal conditions for analyzing UTR4 protein-RNA interactions?

    UTR4 has demonstrated interactions with various RNAs including YML009W-B, NSR1, and NOP1, with prediction scores ranging from 22.74 to 23.27 and z-scores of 1.23 to 1.32 . To further investigate these interactions, researchers should employ RNA immunoprecipitation (RIP) or crosslinking immunoprecipitation (CLIP) methods followed by RNA sequencing. Experimental conditions should include careful buffer optimization to maintain both protein stability and RNA integrity. Based on the catRAPID prediction scores , researchers should initially focus on validating the highest-scoring interactions. Control experiments should include non-specific RNA binding proteins and non-target RNAs to establish specificity. Additional techniques such as electrophoretic mobility shift assays (EMSA) or surface plasmon resonance (SPR) can provide quantitative binding parameters including affinity constants and binding kinetics under varying ionic strength and pH conditions.

  • How can site-directed mutagenesis be applied to elucidate the bifunctional mechanism of UTR4?

    Site-directed mutagenesis represents a powerful approach to dissect the bifunctional nature of UTR4. Based on sequence analysis and structural comparison with other HAD superfamily enzymes with known catalytic mechanisms, researchers should first identify conserved residues likely involved in either the enolase or phosphatase activity. Targeted mutations of these residues should be designed, with conservative substitutions to minimize structural disruption. Following recombinant expression and purification of the mutant proteins, researchers should conduct parallel assays measuring both enzymatic activities separately. Mutations that selectively impair one activity while preserving the other would provide evidence for independent catalytic sites. Complementary structural studies using X-ray crystallography or cryo-electron microscopy of wild-type and mutant proteins, ideally in complex with substrate analogs or transition state mimics, would further elucidate the structural basis of the bifunctional mechanism.

  • What role might UTR4 play in the pathogenicity of Nectria haematococca?

    Nectria haematococca (also known as Fusarium solani) is a plant pathogenic fungus known for its ability to tolerate plant defense compounds like pisatin . While direct evidence linking UTR4 to pathogenicity is not established in the available data, its role in methionine metabolism suggests potential contributions to virulence. The methionine salvage pathway in which UTR4 functions may be particularly important during host colonization, where nutrients can be limited and efficient recycling of sulfur-containing amino acids becomes essential. To investigate this connection, researchers should design gene knockout or RNAi-mediated knockdown experiments targeting UTR4 in N. haematococca, followed by comprehensive pathogenicity assays on host plants. Researchers should measure UTR4 expression levels during different stages of infection using RT-qPCR and assess whether UTR4 activity is upregulated in response to host defense compounds. Additionally, supplementation experiments with methionine metabolites in UTR4-deficient strains could help determine if the pathogenicity defects are directly related to methionine metabolism.

  • How can isothermal titration calorimetry (ITC) and other biophysical methods be employed to characterize UTR4 interactions with substrates and inhibitors?

    Isothermal titration calorimetry (ITC) provides direct measurement of binding thermodynamics between UTR4 and its substrates, products, or potential inhibitors. For comprehensive characterization, researchers should prepare highly purified recombinant UTR4 (>95% purity by SDS-PAGE) and conduct titrations under varying conditions of temperature (15-37°C), pH (6.0-8.5), and buffer composition. The known substrate 5-(methylthio)-2,3-dioxopentyl-P should be synthesized or obtained commercially for these studies . Complementary biophysical techniques should include differential scanning calorimetry (DSC) to assess thermal stability, circular dichroism (CD) to monitor conformational changes upon substrate binding, and microscale thermophoresis (MST) for additional binding affinity measurements. These combined approaches would provide a comprehensive thermodynamic profile of UTR4 interactions and potentially reveal allosteric mechanisms that might regulate its bifunctional activity.

  • What experimental approaches can be used to determine if UTR4 forms oligomeric structures in solution?

    Investigating the oligomeric state of UTR4 is crucial for understanding its structural organization and potential regulatory mechanisms. Researchers should employ a multi-technique approach including size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) to determine absolute molecular weight and oligomeric status in solution. Analytical ultracentrifugation (AUC), specifically sedimentation velocity and equilibrium experiments, would provide additional information about homogeneity and association-dissociation equilibria. Chemical crosslinking followed by mass spectrometry could identify specific protein-protein interaction interfaces. For visualization of oligomeric structures, negative-stain electron microscopy or, if higher resolution is required, cryo-electron microscopy would be appropriate. If oligomerization is substrate-dependent, researchers should perform these analyses both in the presence and absence of substrates, products, and potential allosteric regulators. Understanding the quaternary structure of UTR4 would provide insights into potential cooperative behavior and regulation mechanisms that might be exploited for inhibitor design.

  • How does the kinetic mechanism of UTR4 compare with other enzymes in the methionine salvage pathway?

    A comprehensive kinetic analysis of UTR4 should be conducted to elucidate its catalytic mechanism within the context of the methionine salvage pathway. Steady-state kinetic measurements should determine Km, kcat, and kcat/Km values for both the enolization and dephosphorylation reactions. Pre-steady-state kinetics using rapid kinetic techniques (stopped-flow or quenched-flow) would identify potential rate-limiting steps and reaction intermediates. Comparison of these kinetic parameters with those of upstream and downstream enzymes in the pathway would identify potential metabolic control points. Based on the measured phosphatase activity of 0.7 units/mg with pNPP , researchers should determine if this relatively low activity represents the intrinsic catalytic rate or if activity is substantially higher with the physiological substrate. pH-rate profiles and solvent isotope effects would provide mechanistic insights into proton transfer steps. Finally, researchers should investigate potential regulatory mechanisms such as product inhibition, feedback inhibition by pathway end products, or allosteric regulation by metabolites from interconnected pathways.

Research Methodology Questions

  • What protein purification strategy is optimal for obtaining high-yield, active recombinant UTR4?

    A systematic purification strategy for recombinant UTR4 should begin with selection of an appropriate affinity tag (His6, GST, or MBP) that minimally affects protein folding and activity. Following expression in the chosen system (E. coli, yeast, baculovirus, or mammalian cells), cell lysis should be performed under mild conditions to preserve protein structure. The initial affinity chromatography step should be followed by tag removal using a specific protease (TEV, thrombin, or Factor Xa) if the tag might interfere with activity assays. Secondary purification steps should include ion exchange chromatography to separate charge variants and size exclusion chromatography to ensure homogeneity and remove aggregates. Throughout purification, activity assays using pNPP should monitor recovery of active enzyme . Final yield should be optimized by systematic variation of expression conditions (temperature, inducer concentration, duration) and purification parameters (buffer composition, pH, salt concentration). Quality control should include mass spectrometry to confirm protein identity and integrity, with dynamic light scattering to assess monodispersity before storage at -20°C or -80°C .

Expression SystemTypical YieldPrice RangeRecommended Applications
E. coli0.02-1 mg$815-$1,735Basic enzymatic studies, structural analysis
Yeast0.02-1 mg$995-$2,295Studies requiring fungal post-translational modifications
Baculovirus0.02-1 mg$1,250-$3,475Complex functional studies
Mammalian cells0.02-0.5 mg$1,535-$6,490Studies of host-pathogen interactions

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.